Q4 2023 Holdings
Filed 2024-02-14 | 49 holdings | $1.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $191.7M | 6,495,392 | 10.3% |
| Hillevax Inc | COM | 43157M102 | $157.0M | 9,781,472 | 8.4% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $135.5M | 12,131,705 | 7.2% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $122.6M | 988,460 | 6.6% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $110.0M | 2,725,949 | 5.9% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $109.0M | 2,371,304 | 5.8% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $92.3M | 10,109,279 | 4.9% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $73.1M | 1,164,405 | 3.9% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $59.9M | 3,014,349 | 3.2% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $59.7M | 3,131,008 | 3.2% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $53.0M | 885,165 | 2.8% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $45.6M | 1,523,013 | 2.4% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $45.3M | 785,000 | 2.4% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $44.4M | 3,622,294 | 2.4% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $36.2M | 1,787,527 | 1.9% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $29.2M | 2,667,203 | 1.6% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $28.6M | 997,455 | 1.5% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $28.5M | 1,388,889 | 1.5% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $28.3M | 8,764,232 | 1.5% |
| Aerovate Therapeutics Inc | COM | 008064107 | $27.3M | 1,204,867 | 1.5% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $24.1M | 3,746,857 | 1.3% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $23.1M | 2,401,704 | 1.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $22.9M | 730,917 | 1.2% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $22.3M | 2,000,000 | 1.2% |
| Merus N V | COM | N5749R100 | $20.5M | 746,479 | 1.1% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $19.7M | 2,142,855 | 1.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $19.3M | 899,700 | 1.0% |
| Savara Inc(SVRA) | COM | 805111101 | $18.8M | 4,000,000 | 1.0% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $18.7M | 464,937 | 1.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $16.7M | 393,000 | 0.9% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $16.5M | 1,021,800 | 0.9% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $16.1M | 69,406 | 0.9% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $15.8M | 1,184,840 | 0.8% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $15.3M | 881,173 | 0.8% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $14.2M | 1,026,420 | 0.8% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $14.1M | 397,483 | 0.8% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $12.9M | 317,190 | 0.7% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $11.7M | 285,331 | 0.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $11.7M | 1,995,267 | 0.6% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $11.7M | 523,166 | 0.6% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $11.2M | 400,000 | 0.6% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $9.9M | 7,381,090 | 0.5% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $8.6M | 2,118,051 | 0.5% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $6.2M | 203,684 | 0.3% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $4.7M | 80,000 | 0.3% |
| Bluebird BIO Inc | COM | 09609G100 | $2.4M | 1,709,907 | 0.1% |
| Gritstone BIO Inc(2JQ) | COM | 39868T105 | $2.1M | 1,030,878 | 0.1% |
| Newamsterdam Pharma Company | *W EXP 11/22/202 | N62509117 | $1.6M | 500,333 | 0.1% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $277.6K | 264,377 | 0.0% |